Clinical studies recruiting near Victoria

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

"We Are an Active Family": Promoting Child Physical Activity Through Social Identity Formation in the Family System
NA · Behavioural Medicine Lab, University of Victoria · University of Victoria · NCT05794789 A Study of MGC026 in Participants With Advanced Solid Tumors
Phase 1 · MacroGenics · NCT06242470 A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treat
Phase 2 · BioMarin Pharmaceutical · NCT06668805 Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease
Phase 1 · Mediar Therapeutics · NCT07473323 A Long Term, Observational Follow-Up Study of Children and Young People Who Underwent an 18-Month Course of Oral Immunot
Phase N/A · Murdoch Childrens Research Institute · NCT07359183 A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases
Phase 1 · Sanofi · NCT06647069 Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
Phase 2 · Novartis Pharmaceuticals · NCT05268289 Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small C
Phase 3 · Merck Sharp & Dohme LLC · NCT06170788 SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes
Phase 3 · The George Institute · NCT05345327 No Time to Wait: Single Session Intervention
NA · United Christian Hospital · NCT07383467 Pharmacogenomics for Better Treatment of Fungal Infections Clinical Trial
Phase 2 · The University of Queensland · NCT06510699 A Novel Surgical Criteria for Degenerative Cervical Myelopathy in Chinese Ethnicity
Phase N/A · The University of Hong Kong · NCT06528730 A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive,
Phase 3 · Pfizer · NCT07062965 Effects of NR Supplementation on Metabolic Flexibility in Zone 2 Training
NA · ZHANG Jiaqi · NCT07344636 Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FET
Phase 3 · The University of Hong Kong · NCT03859921 A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Phase 1/Phase 2 · Verastem, Inc. · NCT07020221 Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Ob
Phase 3 · Eli Lilly and Company · NCT06937099 Single Ascending Dose Study of HB2198 in Healthy Participants
Phase 1 · Hinge Bio · NCT07439263 Methadone to Treat Painful Chemotherapy Induced Peripheral Neuropathy
Phase 2/Phase 3 · BC Cancer Victoria · University of British Columbia · NCT05786599 Early Detection of Endometrial/Ovarian Cancer and Hereditary Predisposition of These Cancers
NA · McGill University · NCT04891029 RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune Thrombocytopenia
Phase N/A · Fundación Española de Hematología y Hemoterapía · NCT06919341 Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator
Phase N/A · Abbott Medical Devices · NCT03876054 A Pilot Randomized Controlled Trial of Chatbot Use in Older Adults for Lifestyle Change
NA · The Hong Kong Polytechnic University · NCT06901037 BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
Phase 1 · BeOne Medicines · NCT06120283 Spinal Cord Injury Neurorecovery Collaboration
NA · University of Melbourne · NCT06871254 A Phase Ib/II Trial to Evaluate the Efficacy and Safety of HH-009 for the Treatment of FGF19-positive Advanced or Unrese
Phase 1/Phase 2 · Huahui Health · NCT07547553 Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
Phase 2 · ADARx Pharmaceuticals, Inc. · NCT06990269 Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies
Phase N/A · Spanish Breast Cancer Research Group · NCT03390894 Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor
Phase 2 · Merck Sharp & Dohme LLC · NCT04924075 A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leuke
Phase 3 · Janssen Research & Development, LLC · NCT06852222

Look up another city

Look up another condition